Woodline Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-234,736
| Closed | -$20.3M | – | 604 |
|
|
2023
Q2 | $20.3M | Buy |
234,736
+150,013
| +177% | +$13M | 0.24% | 123 |
|
|
2023
Q1 | $8.24M | Buy |
+84,723
| New | +$8.24M | 0.11% | 223 |
|
|
2022
Q4 | – | Sell |
-204,693
| Closed | -$17.4M | – | 760 |
|
|
2022
Q3 | $17.4M | Sell |
204,693
-198,476
| -49% | -$16.8M | 0.24% | 120 |
|
|
2022
Q2 | $33.4M | Buy |
+403,169
| New | +$33.4M | 0.51% | 38 |
|
|
2022
Q1 | – | Sell |
-447,654
| Closed | -$39.6M | – | 731 |
|
|
2021
Q4 | $39.6M | Buy |
+447,654
| New | +$39.6M | 0.57% | 38 |
|
|
2020
Q2 | – | Sell |
-134,149
| Closed | -$11.3M | – | 155 |
|
|
2020
Q1 | $11.3M | Sell |
134,149
-23,558
| -15% | -$1.99M | 0.81% | 38 |
|
|
2019
Q4 | $13.3M | Buy |
+157,707
| New | +$13.3M | 0.54% | 60 |
|